We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-15.51%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$118M
AUM Growth
-$53.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$34.6M 29.28%
2,747,433
ALLO icon
2
Allogene Therapeutics
ALLO
$604M
$20.5M 17.32%
1,798,163
DYN icon
3
Dyne Therapeutics
DYN
$4.24B
$20.3M 17.18%
2,960,046
CNTA
4
DELISTED
Centessa Pharmaceuticals
CNTA
$19.1M 16.18%
3,931,818
KRON
5
DELISTED
Kronos Bio
KRON
$10.1M 8.51%
2,765,314
PRAX icon
6
Praxis Precision Medicines
PRAX
$8.8B
$7.2M 6.08%
195,955
LIAN
7
DELISTED
LianBio American Depositary Shares
LIAN
$4.93M 4.17%
2,282,084
QTTB icon
8
Q32 Bio
QTTB
$452M
$1.52M 1.28%
42,825

Similar funds

Vida Ventures Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Vida Ventures Advisors held 8 positions worth $118M, down 31% from $172M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's ten largest holdings make up 100% of its $118M portfolio in Q2 2022.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q2 2022.
  • Vida Ventures Advisors's portfolio value fell 31% quarter-over-quarter to $118M.

Based on Vida Ventures Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.